Literature DB >> 30038440

Angiotensin II.

Danial E Baker1, Terri L Levien1.   

Abstract

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

Entities:  

Year:  2018        PMID： 30038440      PMCID： PMC6050881          DOI： 10.1177/0018578718778224

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


  4 in total

Review 1.  Angiotensin II in Refractory Septic Shock.

Authors:  Elio Antonucci; Patrick J Gleeson; Filippo Annoni; Sara Agosta; Sergio Orlando; Fabio Silvio Taccone; Dimitrios Velissaris; Sabino Scolletta
Journal:  Shock       Date:  2017-05       Impact factor: 3.454

Review 2.  Management of Refractory Vasodilatory Shock.

Authors:  Jacob C Jentzer; Saraschandra Vallabhajosyula; Ashish K Khanna; Lakhmir S Chawla; Laurence W Busse; Kianoush B Kashani
Journal:  Chest       Date:  2018-01-09       Impact factor: 9.410

3.  Angiotensin II for the Treatment of Vasodilatory Shock.

Authors:  Ashish Khanna; Shane W English; Xueyuan S Wang; Kealy Ham; James Tumlin; Harold Szerlip; Laurence W Busse; Laith Altaweel; Timothy E Albertson; Caleb Mackey; Michael T McCurdy; David W Boldt; Stefan Chock; Paul J Young; Kenneth Krell; Richard G Wunderink; Marlies Ostermann; Raghavan Murugan; Michelle N Gong; Rakshit Panwar; Johanna Hästbacka; Raphael Favory; Balasubramanian Venkatesh; B Taylor Thompson; Rinaldo Bellomo; Jeffrey Jensen; Stew Kroll; Lakhmir S Chawla; George F Tidmarsh; Adam M Deane
Journal:  N Engl J Med       Date:  2017-05-21       Impact factor: 91.245

Review 4.  Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety.

Authors:  Laurence W Busse; Xueyuan Shelly Wang; Divya M Chalikonda; Kevin W Finkel; Ashish K Khanna; Harold M Szerlip; David Yoo; Sharon L Dana; Lakhmir S Chawla
Journal:  Crit Care Med       Date:  2017-08       Impact factor: 7.598
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.